AgeX Therapeutics, Inc. (AGE)

R&D to Revenue

0.00%

Quarterly · Period ending:

AGE logo

AGE R&D to Revenue

Latest reported0.00%
AGE Quarterly R&D/Revenue (578.28% → 0.00%)
High-resolution chart · PNG

AGE r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
2,424.6154%
0%
-16,892.8571%
17,250%
0%
22,120%
29.3813%
1,896.5517%
6,842.8571%
1,330%
2,187.5%
1,433.3333%
1,883.3333%
7,260%
17,150%
1,012.5%
1,210.8108%
519.6429%
207.1287%
161.0599%
292.5121%
284.0777%
242.2587%
318.0049%
397.3684%
0%
441.853%
318.1579%
275.2155%
620.9205%
253.4934%
377.4536%
377.1523%
578.2772%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.